A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Apr 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ANL SEC filings page.
Adlai Nortye Group Ltd. (ANL) reported $5.0M in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The latest figures depict a lightly debt-funded business whose cash needs far exceed its reported revenue and accounting earnings.
In FY2024, a net loss of$51.9M was almost matched by operating cash flow of-$51.8M . In FY2025, the reported loss widened sharply while operating cash flow remained near the prior year's level, making earnings a less direct guide to cash consumption.
Balance-sheet leverage is modest: FY2025 liabilities remain below
FY2025's reported financing cash flow of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Adlai Nortye Group Ltd.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Adlai Nortye Group Ltd. held $60.9M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $56.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Adlai Nortye Group Ltd. scores 35/100 among other emerging companies.
Not available for Adlai Nortye Group Ltd., and counted as zero in the overall score.
Not available for Adlai Nortye Group Ltd., and counted as zero in the overall score.
Adlai Nortye Group Ltd. reported revenue of $5.0M in fiscal year 2025. Revenue Progress ranks emerging companies on the three-year path of that line, and Adlai Nortye Group Ltd. scores 44/100 among other emerging companies.
Adlai Nortye Group Ltd.'s operations used $56.7M of cash in fiscal year 2025, against $51.8M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Adlai Nortye Group Ltd. scores 45/100 among other emerging companies.
Adlai Nortye Group Ltd.'s cash, cash equivalents and investments came to $60.9M at the end of fiscal year 2025, against $45.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Adlai Nortye Group Ltd. scores 66/100 among other emerging companies.
Adlai Nortye Group Ltd. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
Adlai Nortye Group Ltd. reported a net loss of $109.2M while operations used $56.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q3 2025.
Cash & Balance Sheet
Adlai Nortye Group Ltd. held $60.9M in cash against $425K in long-term debt as of Q3 2025.
Not reported for Q3 2025.
Not reported for Q3 2025.
Margins & Returns
None of these metrics is reported for Q3 2025.
Capital Allocation
None of these metrics is reported for Q3 2025.
ANL Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
ANL Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2510-K | Q3'2410-K | Q3'2310-K | Q3'2210-K |
|---|---|---|---|---|
| Total Assets | $71.3M-45.3% | $130.2M+79.3% | $72.6M | N/A |
| Current Assets | $64.1M-36.7% | $101.2M+52.6% | $66.3M | N/A |
| Cash & Equivalents | $60.9M-33.4% | $91.5M+114.0% | $42.8M-33.3% | $64.1M |
| Total Liabilities | $45.8M-17.0% | $55.1M-82.4% | $313.9M | N/A |
| Current Liabilities | $45.4M-8.7% | $49.7M-84.1% | $312.7M | N/A |
| Non-Current Liabilities | $425K-92.2% | $5.5M+342.5% | $1.2M | N/A |
| Long-Term Debt | $425K-9.4% | $469K-62.1% | $1.2M-88.2% | $10.5M |
| Total Equity | $25.5M-66.0% | $75.0M+131.1% | -$241.3M-30.1% | -$185.4M |
| Retained Earnings | -$429.3M-13.7% | -$377.4M-40.7% | -$268.2M | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Inventory, Accounts Receivable, Long-Term Investments, Goodwill.
ANL Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
ANL Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Asset Turnover, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Adlai Nortye Group Ltd. ANL | FY2025 | $5.0M | -$109.2M | N/A | $971.8M | 32/100 |
| OS Therapies Incorporated OSTX | FY2025 | N/A | -$28.8M | N/A | $75.8M | — |
| Prelude Therapeutics Incorporated PRLD | FY2025 | $12.1M | -$99.5M | N/A | $292.9M | 70/100 |
| MiNK Therapeutics, Inc. INKT | FY2025 | N/A | -$12.5M | N/A | $63.5M | — |
| ABVC BioPharma, Inc. ABVC | FY2025 | $296K | -$7.9M | N/A | $27.0M | — |
| PMV Pharmaceuticals, Inc PMVP | FY2025 | N/A | -$77.7M | N/A | $95.7M | — |
Where Adlai Nortye Group Ltd. Ranks
Frequently Asked Questions
What is Adlai Nortye Group Ltd.'s annual revenue?
Adlai Nortye Group Ltd. (ANL) reported $5.0M in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is Adlai Nortye Group Ltd. profitable?
No, Adlai Nortye Group Ltd. (ANL) reported a net income of -$109.2M in fiscal year 2025.
How much debt does Adlai Nortye Group Ltd. have?
As of fiscal year 2025, Adlai Nortye Group Ltd. (ANL) had $60.9M in cash and equivalents against $425K in long-term debt.
What is Adlai Nortye Group Ltd.'s return on equity (ROE)?
Adlai Nortye Group Ltd. (ANL) has a return on equity of -428.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Adlai Nortye Group Ltd.'s free cash flow?
Adlai Nortye Group Ltd. (ANL) recorded an outflow of $56.9M in free cash flow during fiscal year 2025. This represents a -9.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Adlai Nortye Group Ltd.'s operating cash flow?
Adlai Nortye Group Ltd. (ANL) recorded an outflow of $56.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Adlai Nortye Group Ltd.'s total assets?
Adlai Nortye Group Ltd. (ANL) had $71.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Adlai Nortye Group Ltd.'s capital expenditures?
Adlai Nortye Group Ltd. (ANL) invested $200K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Adlai Nortye Group Ltd.'s current ratio?
Adlai Nortye Group Ltd. (ANL) had a current ratio of 1.41 as of fiscal year 2025, which is considered adequate.
What is Adlai Nortye Group Ltd.'s debt-to-equity ratio?
Adlai Nortye Group Ltd. (ANL) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Adlai Nortye Group Ltd.'s return on assets (ROA)?
Adlai Nortye Group Ltd. (ANL) had a return on assets of -153.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Adlai Nortye Group Ltd.'s P/E ratio?
Adlai Nortye Group Ltd. (ANL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $971.8M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Adlai Nortye Group Ltd.'s price-to-sales ratio?
Adlai Nortye Group Ltd. (ANL) trades at 194x sales, its market capitalization divided by revenue of $5.0M revenue, FY2025. The market capitalization is $971.8M as of Oct 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Adlai Nortye Group Ltd.'s liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Adlai Nortye Group Ltd. (ANL) held $60.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $56.7M over that year. Dividing the one by the other, the reported balance equals about 13 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is Adlai Nortye Group Ltd.'s Piotroski F-Score?
Adlai Nortye Group Ltd. (ANL) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Adlai Nortye Group Ltd.'s earnings high quality?
Adlai Nortye Group Ltd. (ANL) reported a net loss of $109.2M while operations used $56.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Adlai Nortye Group Ltd.?
Adlai Nortye Group Ltd. (ANL) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.